Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease

被引:7
|
作者
Posenau, J. Trevor
Wojdyla, Daniel M.
Shaw, Linda K.
Alexander, Karen P.
Ohman, E. Magnus
Patel, Manesh R.
Smith, Peter K.
Rao, Sunil V.
机构
[1] Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Med Ctr, Div Cardiovasc & Thorac Surg, Durham, NC USA
来源
ANNALS OF THORACIC SURGERY | 2017年 / 104卷 / 01期
关键词
BYPASS SURGERY; INTERVENTION; AGE; STENTS;
D O I
10.1016/j.athoracsur.2016.10.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Balancing risks and benefits of revascularization in elderly patients with multivessel coronary artery disease (CAD) is challenging. The appropriate revascularization strategy for elderly patients with multivessel CAD is unclear. Methods. We used the Duke Databank for Cardiovascular Disease to identify patients aged 75 years or more who had multivessel disease and treatment with percutaneous coronary intervention or coronary artery bypass graft surgery (CABG) within 30 days of the index catheterization between October 1, 2003, and June 30, 2013. The primary outcome was a composite of all-cause death, myocardial infarction, and coronary revascularization through latest follow-up. Associations between baremetal stents (BMS), drug-eluting stents (DES), CABG, and outcomes were determined using multivariable Cox proportional hazards modeling, adjusting for potential confounders with CABG as the reference. Comparisons between BMS and DES were done using BMS as the reference. Results. We identified 763 patients who met the criteria (BMS, n = 202; DES, n = 411; CABG, n = 150). The median age was 79 years (interquartile range, 76 to 82), and the median follow-up was 6.28 years. After adjustment, both BMS and DES were associated with a higher risk of the primary outcome. The BMS versus CAB Ghazard ratio was 1.58 (95% confidence interval: 1.15 to 2.19, p = 0.01). The DES versus CABG hazard ratio was 1.45 (95% confidence interval: 1.08 to 1.95, p = 0.01). The adjusted hazard ratio for DES versus BMS (0.92, 95% confidence interval: 0.71 to 1.19, p = 0.51) was not statistically significant. Conclusions. In this single-center analysis of 763 elderly patients with multivessel disease, CABG was associated with the best overall clinical outcomes, but was selected for a minority of patients. An adequately powered, randomized trial should be considered to define the best treatment strategy for this population. (C) 2017 by The Society of Thoracic Surgeons
引用
收藏
页码:107 / 115
页数:9
相关论文
共 50 条
  • [31] The adequacy of myocardial revascularization in patients with multivessel coronary artery disease
    Zimarino, Marco
    Curzen, Nick
    Cicchitti, Vincenzo
    De Caterina, Raffaele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 1748 - 1757
  • [32] Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease
    Qintar, Mohammed
    Humphries, Karin H.
    Park, Julie E.
    Arnold, Suzanne V.
    Tang, Yuanyuan
    Jones, Phillip
    Salisbury, Adam C.
    Kureshi, Faraz
    Farkouh, Michael E.
    Fuster, Valentin
    Cohen, David J.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (16) : 2074 - 2084
  • [33] Strategies for multivessel revascularization in patients with diabetes
    Lee, Jae-Hwan
    Lee, Seung-Whan
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2013, 2 (03) : 231 - 234
  • [34] Strategies for Multivessel Revascularization in Patients with Diabetes
    Farkouh, Michael E.
    Domanski, Michael
    Sleeper, Lynn A.
    Siami, Flora S.
    Dangas, George
    Mack, Michael
    Yang, May
    Cohen, David J.
    Rosenberg, Yves
    Solomon, Scott D.
    Desai, Akshay S.
    Gersh, Bernard J.
    Magnuson, Elizabeth A.
    Lansky, Alexandra
    Boineau, Robin
    Weinberger, Jesse
    Ramanathan, Krishnan
    Sousa, J. Eduardo
    Rankin, Jamie
    Bhargava, Balram
    Buse, John
    Hueb, Whady
    Smith, Craig R.
    Muratov, Victoria
    Bansilal, Sameer
    King, Spencer, III
    Bertrand, Michel
    Fuster, Valentin
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2375 - 2384
  • [35] REPLY: Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease and Impact of Complete Revascularization on Hard Outcomes in Patients With STEMI
    Velagapudi, Poonam
    Gwon, Yeongjin
    Atti, Varunsiri
    Turagam, Mohit K.
    Abbott, J. Dawn
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (19) : 2309 - 2310
  • [36] Complete Revascularization Strategies in Women and Men With Acute Coronary Syndrome and Multivessel Disease
    Elscot, Jacob J.
    Kakar, Hala
    Dekker, Wijnand K. den
    Bennett, Johan
    Sabate, Manel
    Esposito, Giovanni
    Daemen, Joost
    Boersma, Eric
    Mieghem, Nicolas M. Van
    Diletti, Roberto
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 214 : 25 - 32
  • [37] Revascularization Strategies in Multivessel and Left Main Coronary Artery Disease: SYNTAX and Beyond
    Hahalis, George
    Alexopoulos, Dimitrios
    HELLENIC JOURNAL OF CARDIOLOGY, 2014, 55 (04) : 328 - 335
  • [38] Complete Versus Incomplete Coronary Revascularization of Patients With Multivessel Coronary Artery Disease
    Sandoval Y.
    Brilakis E.S.
    Canoniero M.
    Yannopoulos D.
    Garcia S.
    Current Treatment Options in Cardiovascular Medicine, 2015, 17 (3)
  • [39] Hybrid coronary revascularization for multivessel coronary artery disease
    Hu, Shengshou
    Gao, Runlin
    CORONARY ARTERY DISEASE, 2014, 25 (03) : 258 - 265
  • [40] Hybrid Coronary Revascularization and Coronary Artery Bypass Grafting: A Comparison of Multivessel Coronary Revascularization Strategies
    Lawler, T.
    Stone, B.
    Ahmad, S.
    Panza, A.
    Louis, L.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : S26 - S26